Abstract | OBJECTIVE: METHOD: The patients were randomly divided into two groups and administrated montelukast sodium and loratadine respectively for two weeks. The specific IgE in serum and eosinophil in peripheral blood and nose secretion smear of patients were detected and then the state was evaluated by patients themselves and doctors. RESULT:
After treatment the level of specific IgE in serum and eosinophil count in peripheral blood and nose secretion smear of patients were significantly lower than that before treatment (P < 0.05); There were no significant differences in the change of the level of specific IgE in serum and eosinophil count in peripheral blood and nose secretion smear between two groups after treatment (P > 0.05). CONCLUSION:
|
Authors | Xiaoling Liu, Zhimin Xing, Zhihong Gao |
Journal | Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology
(Lin Chuang Er Bi Yan Hou Ke Za Zhi)
Vol. 19
Issue 8
Pg. 337-9
(Apr 2005)
China |
PMID | 16075981
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Acetates
- Cyclopropanes
- Histamine H1 Antagonists, Non-Sedating
- Leukotriene Antagonists
- Quinolines
- Sulfides
- Immunoglobulin E
- Loratadine
- montelukast
|
Topics |
- Acetates
(therapeutic use)
- Adult
- Cyclopropanes
- Eosinophils
- Female
- Histamine H1 Antagonists, Non-Sedating
(therapeutic use)
- Humans
- Immunoglobulin E
(blood)
- Leukotriene Antagonists
(therapeutic use)
- Loratadine
(therapeutic use)
- Male
- Quinolines
(therapeutic use)
- Rhinitis, Allergic, Seasonal
(blood, drug therapy)
- Sulfides
|